BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

961 related articles for article (PubMed ID: 6197163)

  • 61. [Significance of prostate fluid carcinoembryonic antigen in the diagnosis of prostate cancer].
    Hayashi T; Yamauchi A; Hosoda K
    Hinyokika Kiyo; 1995 Jul; 41(7):525-8. PubMed ID: 7545350
    [TBL] [Abstract][Full Text] [Related]  

  • 62. ["Non-specific cross reacting antigen (NCA)", a tracer of human granulocytes and monocytes].
    Burtin P
    C R Seances Soc Biol Fil; 1979; 173(2):261-9. PubMed ID: 92357
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Antigenic structures of CEA and CEA-related normal antigens and problems related to the determination of blood CEA concentrations].
    Matsuoka Y; Kuroki M; Koga Y
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):575-84. PubMed ID: 6192762
    [TBL] [Abstract][Full Text] [Related]  

  • 64. CEA and NCA levels in peripheral and tumour venous blood of patients with gastric and colonic carcinomas estimated by RIA and EIA methods.
    Harłozińska A; Rachel F; Gawlikowski W; Richter R; Kołodziej J
    Eur J Surg Oncol; 1991 Feb; 17(1):59-64. PubMed ID: 1995360
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Organ-specific human prostate beta-globulin during tumor growth].
    Nikolaev AA; Afanas'eva AV; Khaĭrullin IuKh
    Biull Eksp Biol Med; 1980 Nov; 90(11):583-6. PubMed ID: 6160885
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chromosomal localization of the carcinoembryonic antigen gene family and differential expression in various tumors.
    Zimmermann W; Weber B; Ortlieb B; Rudert F; Schempp W; Fiebig HH; Shively JE; von Kleist S; Thompson JA
    Cancer Res; 1988 May; 48(9):2550-4. PubMed ID: 3356015
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oncofetal antigens in sacrococcygeal teratomas.
    Kuhajda FP; Taxy JB
    Arch Pathol Lab Med; 1983 May; 107(5):239-42. PubMed ID: 6188436
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Keratin immunoreactivity in the benign and neoplastic human prostate.
    Brawer MK; Peehl DM; Stamey TA; Bostwick DG
    Cancer Res; 1985 Aug; 45(8):3663-7. PubMed ID: 2410099
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunological reactivity of mucinous and serous ovarian adenocarcinomas.
    Harłozińska-Szmyrka A; Slesak B; Richter R; Rabczyński J; Cisło M
    Cancer Detect Prev; 1986; 9(3-4):347-58. PubMed ID: 3017557
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Carcinoembryonic antigen (CEA) in gallbladder bile and mucosa in cholecystolithiasis.
    Akiyama H; Yamamoto M; Sumiyoshi H; Tahara E; Iwamori S
    Acta Chir Scand; 1986; 152():509-13. PubMed ID: 3788394
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Density distribution and antigenic characterization of cell subpopulations isolated from cystic fluids of ovarian serous neoplasms.
    Harłozińska A; Bar JK; Rabczyński J; Noworolska A; Richter R; Cisło M
    Anticancer Res; 1989; 9(1):161-6. PubMed ID: 2705745
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tumor associated glycoprotein-72 is highly expressed in prostatic adenocarcinomas.
    Myers RB; Meredith RF; Schlom J; LoBuglio AF; Bueschen AJ; Wheeler RH; Stockard CR; Grizzle WE
    J Urol; 1994 Jul; 152(1):243-6. PubMed ID: 8201675
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Immunohistochemistry of the prostate and prostate carcinomas].
    Wernert N
    Veroff Pathol; 1991; 135():1-163. PubMed ID: 2038892
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunohistochemical demonstration of tumor-associated antigens in prostatic carcinomas of various histological differentiations.
    Friedmann W; Steffens J; Lobeck H; Blümcke S; Nagel R
    Eur Urol; 1985; 11(1):52-6. PubMed ID: 2580711
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay.
    Kuriyama M; Wang MC; Papsidero LD; Killian CS; Shimano T; Valenzuela L; Nishiura T; Murphy GP; Chu TM
    Cancer Res; 1980 Dec; 40(12):4658-62. PubMed ID: 6159971
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Metastasis and markers].
    Trinchieri A; Rovera F; Longo G; Del Nero A; Zanetti G; Austoni E
    Arch Ital Urol Nefrol Androl; 1992 Mar; 64(1):27-30. PubMed ID: 1373913
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunofluorescence studies on the occurrence and localization of the CEA-related biliary glycoprotein I (BGP I) in normal human gastrointestinal tissues.
    Svenberg T; Hammarström S; Zeromski J
    Clin Exp Immunol; 1979 Jun; 36(3):436-41. PubMed ID: 385181
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The incidence and significance of serum hCG and CEA in patients with gastrointestinal malignant tumors.
    Birkenfeld S; Noiman G; Krispin M; Schwartz S; Zakut H
    Eur J Surg Oncol; 1989 Apr; 15(2):103-8. PubMed ID: 2703054
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CEA and NCA in benign and malignant breast tumors.
    Nap M; Keuning H; Burtin P; Oosterhuis JW; Fleuren G
    Am J Clin Pathol; 1984 Nov; 82(5):526-34. PubMed ID: 6388310
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ultrastructural localizations of beta-microseminoprotein, a prostate-specific antigen, in human prostate and sperm: comparison with gamma-seminoprotein, another prostate-specific antigen.
    Ito Y; Tsuda R; Kimura H
    J Lab Clin Med; 1989 Sep; 114(3):272-7. PubMed ID: 2475560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.